It's Not Pot: Regulating Hemp-Based Cannabinoids

Sunday, March 14, 2021

2:30 PM – 3:30 PM ET

Location: Live

CE: 1

Learning Level: 2
Activity Type: Knowledge-Based
ACPE Number: 0202-0000-21-006-H03-P, 0202-0000-21-006-L03-P
Number of Hours: 1

Speaker(s)

Kim J. Sveska, M.S., J.D.

Principal
Foley, Baron, Metzger & Juip
Milford, Michigan, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation PDF

Hemp-based cannabinoids could hit the market soon, but not without hitting a few hurdles first. While the U.S. Food and Drug Administration recognizes the health benefits of cannabinoids, some companies market their cannabinoid-containing products in ways that violate the Federal Food, Drug, and Cosmetic Act. Irresponsible marketing puts Americans’ health and safety at risk. Join us for an enlightening, expert-led discussion about cannabidiol and industrial hemp legislation and how it could affect the future use of and access to these products.

Learning Objectives:

Discuss how cannabidiol and industrial hemp are addressed in current marijuana legislation.
Identify various pharmacologically active hemp-derived phytocannabinoids.
Explain the current U.S. Food and Drug Administration position on products containing hemp-based cannabinoids and the associated marketing of these products.
Discuss overall trends and the future of hemp-based cannabinoid use and access.